Eileen V. Pitpitan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eileen V. Pitpitan has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Heather A. Pines
Herbert Wertheim School of Public Health, University of California San Diego, La Jolla, California, USA
2 shared publications - Laramie R. Smith
School of Medicine University of California San Diego La Jolla California USA
2 shared publications - Aaron Gutierrez
Department of Medicine, University of California, 9500 Gilman Drive, #0507, San Diego, CA, 92093-0507, United States, 1 858 822 1462, 1 858 534 6084
1 shared publication - Albert Genegaling
Department of Medicine, University of California, 9500 Gilman Drive, #0507, San Diego, CA, 92093-0507, United States, 1 858 822 1462, 1 858 534 6084
1 shared publication - Alicia Vera
Department of Medicine, University of California, San Diego, San Diego, USA
1 shared publication - Angel B. Algarin
Center for Health Promotion and Disease Prevention, Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, USA
1 shared publication
Latest Publications
- Open Access
Polysubstance Injection and Smoking Trajectories of Unregulated Drug Use in the San Diego-Tijuana Border Region: A Latent Transition Analysis
Background and Aims: The North American overdose crisis is increasingly characterized by complex polysubstance use alongside a transition from injecting to smoking unregulated opioids. However, transitions involving multiple substances remain understudied. We characterized longitudinal transitions in the route of administration and frequency of heroin, fentanyl, and methamphetamine use and examined whether these transitions differed by multilevel factors hypothesized to influence patterns of polysubstance use and routes of administration over time. Design: People who inject drugs (PWID) enrolled in a cohort study completed baseline surveys (October 2020–2021) and three biannual follow-up visits (through April 2023). Setting: San Diego, California, and Tijuana, Baja California. Participants: Among 612 PWID, median age was 43 years; most were male (74%), Hispanic, Latino, or Mexican (72%), and San Diego residents (67%). Measurements: Based on past six-month substance use behaviors reported at each visit, we categorized participants according to six indicators over time: low- (< weekly) and high-frequency (≥ weekly) smoking and injecting of heroin, fentanyl, and methamphetamine. We then used latent transition analysis (LTA) to identify distinct subgroups of participants with respect to these indicators at baseline and examine transitions between them over 18 months. We fit models with 2–5 subgroups, selecting the final model based on fit and interpretability and used multiple-groups LTA to examine differences in subgroup transitions by multilevel factors. Findings: We identified four subgroups: Subgroup 1 (“ Heroin-Methamphetamine Polyroute ”), characterized by high-frequency heroin and methamphetamine smoking and injection, included 22% of participants at baseline but 0% at 18 months. Subgroup 2 (“ Methamphetamine-dominant Smoking ”), characterized by high-frequency methamphetamine smoking, accounted for 14% of participants at baseline and 18 months. Subgroup 3 (“ Fentanyl-Methamphetamine Smoking ”), characterized by high-frequency fentanyl and methamphetamine smoking, included 4% of participants at baseline and 21% at 18 months. Subgroup 4 (“ Heroin-dominant Injecting ”), characterized by high-frequency heroin injection, included 61% of participants at baseline and 65% at 18 months. Participants in Subgroup 1 primarily transitioned to Subgroups 3 and 4 over time. Larger increases in Subgroup 3 prevalence occurred for participants who, at baseline, experienced homelessness, resided in San Diego (vs. Tijuana), received syringes from a syringe services program, and overdosed in the past six months. Conclusions: PWID in this region increasingly transitioned from high-frequency heroin and methamphetamine injection toward fentanyl and methamphetamine smoking, likely reflecting shifts in drug availability. Results highlight the need for multilevel interventions that address health harms resulting from polysubstance smoking alongside continued injection.
Open AccessPolysubstance Injection and Smoking Trajectories of Unregulated Drug Use in the San Diego-Tijuana Border Region: A Latent Transition Analysis
Background and Aims: The North American overdose crisis is increasingly characterized by complex polysubstance use alongside a transition from injecting to smoking unregulated opioids. However, transitions involving multiple substances remain understudied. We characterized longitudinal transitions in the route of administration and frequency of heroin, fentanyl, and methamphetamine use and examined whether these transitions differed by multilevel factors hypothesized to influence patterns of polysubstance use and routes of administration over time. Design: People who inject drugs (PWID) enrolled in a cohort study completed baseline surveys (October 2020–2021) and three biannual follow-up visits (through April 2023). Setting: San Diego, California, and Tijuana, Baja California. Participants: Among 612 PWID, median age was 43 years; most were male (74%), Hispanic, Latino, or Mexican (72%), and San Diego residents (67%). Measurements: Based on past six-month substance use behaviors reported at each visit, we categorized participants according to six indicators over time: low- (< weekly) and high-frequency (≥ weekly) smoking and injecting of heroin, fentanyl, and methamphetamine. We then used latent transition analysis (LTA) to identify distinct subgroups of participants with respect to these indicators at baseline and examine transitions between them over 18 months. We fit models with 2–5 subgroups, selecting the final model based on fit and interpretability and used multiple-groups LTA to examine differences in subgroup transitions by multilevel factors. Findings: We identified four subgroups: Subgroup 1 (“ Heroin-Methamphetamine Polyroute ”), characterized by high-frequency heroin and methamphetamine smoking and injection, included 22% of participants at baseline but 0% at 18 months. Subgroup 2 (“ Methamphetamine-dominant Smoking ”), characterized by high-frequency methamphetamine smoking, accounted for 14% of participants at baseline and 18 months. Subgroup 3 (“ Fentanyl-Methamphetamine Smoking ”), characterized by high-frequency fentanyl and methamphetamine smoking, included 4% of participants at baseline and 21% at 18 months. Subgroup 4 (“ Heroin-dominant Injecting ”), characterized by high-frequency heroin injection, included 61% of participants at baseline and 65% at 18 months. Participants in Subgroup 1 primarily transitioned to Subgroups 3 and 4 over time. Larger increases in Subgroup 3 prevalence occurred for participants who, at baseline, experienced homelessness, resided in San Diego (vs. Tijuana), received syringes from a syringe services program, and overdosed in the past six months. Conclusions: PWID in this region increasingly transitioned from high-frequency heroin and methamphetamine injection toward fentanyl and methamphetamine smoking, likely reflecting shifts in drug availability. Results highlight the need for multilevel interventions that address health harms resulting from polysubstance smoking alongside continued injection.
- Open Access
- 27 February 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15 (1) , e72334
A Novel Social Network Approach to Measure Intersectional Stigma Among Latino Men Who Have Sex With Men in San Diego, California (NEXUS): Protocol for a Longitudinal Cohort Study
Background: Latino men who have sex with men (LMSM) account for a disproportionate and growing number of HIV diagnoses in the United States. Intersectional stigma remains a key driver of HIV inequities; however, most quantitative intersectional stigma measures are limited and do not consider the larger social context. Objective: NEXUS is a longitudinal cohort study that will use social network methods and theory to rigorously measure intersectional stigma among LMSM and quantify the longitudinal association between intersectional stigma and HIV prevention outcomes. Methods: We will prospectively enroll 500 HIV-negative LMSM in San Diego, California, and follow participants over 1 year. At baseline and every 6 months thereafter (Month 0, Month 6, and Month 12), participants will complete an interviewer-administered social network inventory and a self-administered survey to collect information on their social networks (alter types, size, and characteristics) and HIV prevention engagement (HIV testing and pre-exposure prophylaxis use), respectively. Information on HIV prevention engagement will also be abstracted from medical records. Intersectional stigma will be operationalized as a multilevel latent variable comprised of observed measures of anticipated and enacted stigma experienced by a participant from an alter toward the participant’s Latino, masculine, and sexual identities. Multilevel structural equation modeling will be used to estimate the longitudinal association between intersectional stigma, HIV testing, and pre-exposure prophylaxis use, considering potential mediators and moderators. Results: NEXUS recruitment began in June 2021, and as of March 11, 2025, a total of 482 participants had been enrolled. Enrollment is planned to end by May 2025, with baseline results expected late 2025 and through the following year. Data collection for our prospective study aims is expected to be complete in June 2026, with data analysis and expected results published later that year. Conclusions: NEXUS will advance quantitative intersectional stigma measurement using a novel social network approach. This study will identify intervention targets to reduce HIV inequities among LMSM and mitigate the harms of intersectional stigma in this population.
- 27 February 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15 (1) , e72334
Open AccessA Novel Social Network Approach to Measure Intersectional Stigma Among Latino Men Who Have Sex With Men in San Diego, California (NEXUS): Protocol for a Longitudinal Cohort Study
Background: Latino men who have sex with men (LMSM) account for a disproportionate and growing number of HIV diagnoses in the United States. Intersectional stigma remains a key driver of HIV inequities; however, most quantitative intersectional stigma measures are limited and do not consider the larger social context. Objective: NEXUS is a longitudinal cohort study that will use social network methods and theory to rigorously measure intersectional stigma among LMSM and quantify the longitudinal association between intersectional stigma and HIV prevention outcomes. Methods: We will prospectively enroll 500 HIV-negative LMSM in San Diego, California, and follow participants over 1 year. At baseline and every 6 months thereafter (Month 0, Month 6, and Month 12), participants will complete an interviewer-administered social network inventory and a self-administered survey to collect information on their social networks (alter types, size, and characteristics) and HIV prevention engagement (HIV testing and pre-exposure prophylaxis use), respectively. Information on HIV prevention engagement will also be abstracted from medical records. Intersectional stigma will be operationalized as a multilevel latent variable comprised of observed measures of anticipated and enacted stigma experienced by a participant from an alter toward the participant’s Latino, masculine, and sexual identities. Multilevel structural equation modeling will be used to estimate the longitudinal association between intersectional stigma, HIV testing, and pre-exposure prophylaxis use, considering potential mediators and moderators. Results: NEXUS recruitment began in June 2021, and as of March 11, 2025, a total of 482 participants had been enrolled. Enrollment is planned to end by May 2025, with baseline results expected late 2025 and through the following year. Data collection for our prospective study aims is expected to be complete in June 2026, with data analysis and expected results published later that year. Conclusions: NEXUS will advance quantitative intersectional stigma measurement using a novel social network approach. This study will identify intervention targets to reduce HIV inequities among LMSM and mitigate the harms of intersectional stigma in this population.
- Open Access
- 8 November 2025
- Published by Elsevier in Social Science & Medicine
- Vol. 388, 118757
Occupational stress and substance use-related stigma among criminal attorneys
- 8 November 2025
- Published by Elsevier in Social Science & Medicine
- Vol. 388, 118757
Open AccessOccupational stress and substance use-related stigma among criminal attorneys